Boyd Peter E.
- SEC CIK
- 0001739816
In the past year, 3 open-market sale filings worth $257.3K and no purchases.
Current role at each company
- AQST Aquestive Therapeutics, Inc.Chief People Officeras of Sep 10, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $257.3K
- 3 filings
- Net
- −$257.3K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Boyd Peter E. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 11, 2026 (view filing) | Mar 10 | 1 day | Boyd Peter E.Chief People Officer | SSale | −29.8K | $4.17 | −$124.3K | −8.1%338.5K after | |
| Oct 17, 2025 (view filing) | Oct 15 | 2 days | Boyd Peter E.See Remarks | SSale | −10.0K | $7.00 | −$70.0K | −3.6%268.3K after | 10b5-1 |
| Sep 29, 2025 (view filing) | Sep 26 | 3 days | Boyd Peter E.See Remarks | SSale | −10.0K | $6.30 | −$63.0K | −3.5%278.3K after | 10b5-1 |
| Sep 8, 2025 (view filing) | Sep 5 | 3 days | Boyd Peter E.See Remarks | SSale | −15.0K | $5.30 | −$79.5K | −4.9%288.3K after | 10b5-1 |
| Jun 15, 2022 (view filing) | Jun 14 | 1 day | Boyd Peter E.SVP-Bus. Process & Info. Tech. | PPurchase | +5.00K | $0.81 | +$4.05K | +9.2%59.5K after | |
| Jun 10, 2022 (view filing)5:26 PM ET | Jun 8 | 2 days | Boyd Peter E.SVP-Bus. Process & Info. Tech. | PPurchase | +2.29K | $0.96 | +$2.20K | +4.4%54.5K after | |
| Jun 10, 2022 (view filing)5:26 PM ET | Jun 8 | 2 days | Boyd Peter E.SVP-Bus. Process & Info. Tech. | PPurchase | +2.29K | $0.13 | +$298.09 | –2.29K after | Derivative |